Liquid biomarkers in active surveillance

In the past two decades, new biomarkers for prostate cancer detection and risk prediction have become available for clinical use. While tissue-based gene expression assays offer molecular risk assessment after diagnoses, several serum- and urine-based 'liquid' biomarkers are available for the pre-biopsy setting which may also play a role for active surveillance (AS).The medical literature was queried utilizing PubMed (pubmed.ncbi.nlm.nih.gov)...